Skip to main content
. 2015 Nov 23;109(1):174–184. doi: 10.1093/cvr/cvv254

Figure 6.

Figure 6

Proposed mechanism by which OA-NO2 reduces fibrosis in the atrium of AngII-treated mice. OA-NO2 decreases fibroblast transdifferentiation through inhibition of Smad-2 activation, as indicated by a reduction of α-SMA expression. Additionally, OA-NO2 reduces atrial oxidative stress due to attenuation of superoxide production from macrophages and fibroblasts by inhibition of NOX2 and p67 phox expression via p38 MAPK deactivation.